new_0222_0727|ANPC|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0727|ANPC|1|AnPac Bio-Medical Science Co Ltd Total Current Assets (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Cash and Short Term Investments (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Inventories (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Net PP&E (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Goodwill and Intangibles (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Total Liabilities (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Total Current Liabilities (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Total Long Term Liabilities (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Total Deposits (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Book Value (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Retained Earnings (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Treasury Stock (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd EV to Revenues|AnPac Bio-Medical Science Co Ltd EV to Earnings|AnPac Bio-Medical Science Co Ltd EV to Free Cash Flow|AnPac Bio-Medical Science Co Ltd EV to Assets (Quarterly)|AnPac Bio-Medical Science Co Ltd PS Ratio|AnPac Bio-Medical Science Co Ltd PE Ratio|AnPac Bio-Medical Science Co Ltd Price to Book Value|AnPac Bio-Medical Science Co Ltd PEG Ratio|AnPac Bio-Medical Science Co Ltd Debt to Equity Ratio|AnPac Bio-Medical Science Co Ltd Dividend Yield|AnPac Bio-Medical Science Co Ltd Shareholder Yield (TTM)|AnPac Bio-Medical Science Co Ltd Percent of Shares Outstanding Short|AnPac Bio-Medical Science Co Ltd Total Receivables (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Total Payables (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Total Capital Stock (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Return on Invested Capital|AnPac Bio-Medical Science Co Ltd Quality Ratio Score|AnPac Bio-Medical Science Co Ltd Momentum Score|AnPac Bio-Medical Science Co Ltd Beta (1Y)|AnPac Bio-Medical Science Co Ltd Sustainable Growth Rate (TTM)|AnPac Bio-Medical Science Co Ltd Institutional Investor Ownership Percentage|AnPac Bio-Medical Science Co Ltd Average Diluted Shares Outstanding (Quarterly)|AnPac Bio-Medical Science Co Ltd Total Employees (Annual)|AnPac Bio-Medical Science Co Ltd EPS Diluted (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd SG&A Expense (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Shares Outstanding|AnPac Bio-Medical Science Co Ltd Repurchase of Capital Stock (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Ordinary Shares Number (Quarterly)|AnPac Bio-Medical Science Co Ltd Payout Ratio|AnPac Bio-Medical Science Co Ltd Quick Ratio (Quarterly)|AnPac Bio-Medical Science Co Ltd Normalized Diluted EPS (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Stock Buybacks (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Effective Tax Rate (TTM)|AnPac Bio-Medical Science Co Ltd Return on Equity|AnPac Bio-Medical Science Co Ltd Net Income (TTM) (USD)|AnPac Bio-Medical Science Co Ltd Revenue (TTM) (USD)|AnPac Bio-Medical Science Co Ltd Dividend Per Share (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Revenue (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Gross Profit (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Pre-Tax Income (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Net Income (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Net Interest Income (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Price (USD)|AnPac Bio-Medical Science Co Ltd Total Return Price (USD)|AnPac Bio-Medical Science Co Ltd Enterprise Value (USD)|AnPac Bio-Medical Science Co Ltd 30-Day Average Daily Volume|AnPac Bio-Medical Science Co Ltd 1 Year Price Returns (Daily)|AnPac Bio-Medical Science Co Ltd Short Interest|AnPac Bio-Medical Science Co Ltd PE Ratio (Forward)|AnPac Bio-Medical Science Co Ltd PE Ratio (Forward 1y)|AnPac Bio-Medical Science Co Ltd PS Ratio (Forward)|AnPac Bio-Medical Science Co Ltd PS Ratio (Forward 1y)|AnPac Bio-Medical Science Co Ltd Quarterly EPS Estimates (USD)|AnPac Bio-Medical Science Co Ltd Quarterly Revenue Estimates (USD)|AnPac Bio-Medical Science Co Ltd Quarterly EPS Surprise|AnPac Bio-Medical Science Co Ltd Quarterly Revenue Surprise|AnPac Bio-Medical Science Co Ltd Quarterly Actual EPS (USD)|AnPac Bio-Medical Science Co Ltd Quarterly Actual Revenue (USD)|AnPac Bio-Medical Science Co Ltd Revenue Estimates for Current Fiscal Year (USD)|AnPac Bio-Medical Science Co Ltd Revenue Estimates for Next Fiscal Year (USD)|AnPac Bio-Medical Science Co Ltd Price Target (USD)|AnPac Bio-Medical Science Co Ltd Consensus Recommendation|AnPac Bio-Medical Science Co Ltd Price Target Num Estimates|AnPac Bio-Medical Science Co Ltd EPS Estimates for Current Fiscal Year (USD)|AnPac Bio-Medical Science Co Ltd EPS Estimates for Next Fiscal Year (USD)|AnPac Bio-Medical Science Co Ltd Research and Development Expense (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Reconciled Depreciation (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Non-Operating Interest Expense (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Land and Improvements (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Buildings and Improvements (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Other Properties (Quarterly) (USD)|AnPac Bio-Medical Science Co Ltd Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0727|ANPC|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0727|ANPC|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|yearly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0727|ANPC|5|143.428571429|143.428571429|143.428571429|143.428571429|143.428571429|143.428571429|143.428571429|143.428571429||143.428571429|143.428571429||1.44444444444|91.3333333333|1.43827160494|91.4|1.44444444444||1.44761904762||111.555555556|1.4450867052|91.3333333333|15.2291666667|143.428571429|143.428571429|143.428571429|91.3333333333|91.3333333333|34|30.4166666667|92|32.6428571429|111.555555556|229|111.555555556|111.555555556|65.9|365|143.428571429|91.3333333333|111.555555556|111.555555556|91.2857142857|91.3333333333|92|91.3333333333|91.3333333333||111.555555556|111.555555556|111.555555556|111.555555556|111.555555556|1.4450867052|1.4450867052|1.4450867052|1.44489795918|1.43609022556|15.2291666667|||1.44396551724|||121.666666667||92||92|64.75|108.75|54.375|48.3333333333|54.375|79.6666666667|98|111.555555556|182.5|111.555555556||182.75||182.75||
new_0222_0727|ANPC|6|7|7|7|7|7|7|7|7||7|7||477|6|162|5|477||315||9|519|6|48|7|7|7|6|6|9|12|1|14|9|2|9|9|10|1|7|6|9|9|7|6|1|6|6||9|9|9|9|9|519|519|519|490|266|48|||232|||3||1||1|8|4|8|9|8|3|1|9|2|9||4||4||
new_0222_0727|ANPC|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0727|ANPC|201809|||||||||||||||||||||||||||||||||||||||-0.107|||||||||||||||||||||||||||||||||||||||||||||||
new_0222_0727|ANPC|201812|3.0313|1.8734|0.009|2.6372|1.2867|10.9253|10.3849|0.5403||-3.2553|-25.3457||||||||||-1.1593||||0.4387|5.7664|0.0827|||||||11.2014||-0.127|1.7507|||11.5347||0.2226|-0.1166|||||||0.5233|0.2286|-1.4257|-1.4225|-0.0359||||||||||||||||||||||||0.3413|0.1796|0.0359||2.2926||1.3072||
new_0222_0727|ANPC|201909|5.3925|3.3654|0.0376|2.6843|1.2073|15.7179|15.2902|0.4277||-5.6252|-34.09||||||||||-0.74||||1.1999|9.7387|0.0695|||||||11.5347|101|-0.418|4.3805|||11.5347||0.2986|-0.4174|-2.9893||||||0.5978|0.3168|-4.7819|-4.8217|-0.0874||||||||||||||||||||||||0.373|0.1462|0.0874||2.25||1.3685||
new_0222_0727|ANPC|201912|3.1687|0.8754|0.0447|2.6967|1.2316|9.8482|9.461|0.3872||-2.2829|-39.5145||||||||||-2.4146|||0.016|0.2644|2.7432|0.0939|||||||9.868|111|-0.4683|3.0962|9.868||9.868||0.1205|-0.4313|||||||0.3878|0.135|-4.7207|-4.6216|-0.1011|10.12|10.12|118.002|||1789|||36.8884||||||||1.513|||||||0.3834|0.1051|0.1011||2.2909||1.5553|8.5|
new_0222_0727|ANPC|202003|||||||||||||55.3944|-6.5482|||50.8869||||||1.2994|0.0117||||-1803.6608|2|||||10.7717||-0.2793|3.321|11.2014|||||-0.27||0.1552||-13.8808|1.6409||0.1319|0.0431|-3.0412|-3.015|-0.0381|7.7|7.7|90.8946|6056.9333||1305|||28.0673||||||||2|10|18|1|1|||0.4207||0.0381|||||7.5|7.7
new_0222_0727|ANPC|202006|3.5109|1.4056|0.0289|2.6539|1.1703|4.2192|3.7289|0.4903||3.4084|-46.8948||36.6103|-3.2809||7.4273|35.6978||16.8923||0.2483||0.874|0.0046|0.4406|0.496|0.1056|-1051.1061|3|||||11.1328||-0.447|4.4157|11.2014||11.2014||0.4951|-0.4197|-14.1946|0.1164||-17.3953|1.5589||0.4414|0.2166|-4.9187|-4.937|-0.0354|5.14|5.14|57.0723|8212.3333||516|||18.7358||||||||||18|1|1|-1|-0.72|0.634||0.0354|||||6.35|5.43
new_0222_0727|ANPC|202009|||||||||||||25.117|-2.8491|||24.6561||12.2913||||1.8017|0.0716||||-714.3244|3||||0.0237|11.6829||-0.1589|2.4157||||||-0.1831||0.3862||-14.5273|1.6479||0.6867|0.3772|-1.9372|-1.9536|-0.0092|3.74|3.74|41.3904|113532.4667||8023|||13.6327|||1.2|||||1.984|6.814|18|1|1|-1|-0.72|0.5471||0.0092|||||3.2075|5.74
new_0222_0727|ANPC|202012|3.2584|0.4616|0.0478|2.949|1.2222|7.1342|6.6619|0.4723||0.4512|-54.6356||21.4025|-5.6066||8.4791|19.6052||141.6044||2.7924||0.9086|0.0796|1.3881|2.396|0.1238|-372.1572|7||1.9412||1.3484|11.1729|86|-0.1463|3.5|12.0558||12.0558||0.2777|-0.1302||0.1104||-11.548|3.0251||1.765|1.2717|-1.6783|-1.6423|-0.0848|5.3|5.3|64.7445|2630021.8333|-33.9152|9601|||20.2303|||1.3|||||3.073|8.2635|13|1|2|-0.97||0.0535||0.0848||2.4534||1.7832|5.55|6.61
new_0222_0727|ANPC|202103|5.0585|1.3704|0.1477|2.9145|1.1972|8.0184|7.5534|0.4651||1.3279|-58.6419||22.9915|-5.7093||7.9311|21.3023||54.3836||2.5606||0.5849|0.1354|1.2483|0.1677|0.1522|-360.7154|5|2|3.1817||3.3705|11.958||-0.3745|3.5586|12.6563||12.6563||0.3467|-0.3727||0.0998||-13.007|3.2299||0.3368|0.1968|-4.5109|-4.4741|-0.0962|5.99|5.99|74.261|1619035.4|-22.2078|16329|||||||||-0.37||6.527||8||1|||0.5172||0.0962|||||5.75|4.32
new_0222_0727|ANPC|202106|6.2967|1.327|0.0698|3.0109|1.1861|7.4921|7.1639|0.3282||3.2264|-64.0343||17.4529|-5.4631|-3.1912|6.3522|12.9463||20.8713||0.5597||-31.9556|2.0967|4.12|2.3556|0.1646|-314.0478|7|1|4.7391|-1011.6387|1.09|12.9481||-0.3328|4.5337|15.9951||15.9951||0.7603|-0.3323|-4.0212|0.1164|-1011.6387|-12.4047|3.8829||1.0944|0.6818|-4.4055|-4.3347|-0.247|4.21|4.21|67.768|2113376.3|-18.0934|335370||||||1.518||-27.5362||1.1|5.404|8.931|8||1|||0.3498||0.247|||||3.88|3.61
new_0222_0727|ANPC|202109|3.4486|0.8441|0.0536|3.1454|4.5755|10.536|9.8652|0.6708||-0.0498|-68.6905||16.0421|-4.1027|-2.9305|5.476|10.7485||14.698||-93.1859||-38.0737|0.1363|1.2498|0.8375|0.182|-357.8786|5|2|4.5445|-906.7595|1.0322|15.3981||-0.2996|3.6872|17.7658||17.7658||0.2123|-0.3303||0.1326|-906.7595|-15.1685|3.8793||0.6831|0.3754|-4.8377|-4.7175|-0.2965|3.24|3.24|62.2319|134043.1667|-13.369|24210||||||1.643||-58.308||0.685||||||||0.9646||0.2965|||||2.54|1.68
new_0222_0727|ANPC|202112|||||||||||||6.7912||-1.2406||4.0473|||||||0.3214||||||1|-0.0844||1.0252||||||||||||||||||||||1.22|1.22|26.345|333989.0333|-76.9811|57091|||||||||||||||||||||||||0.7916|0.7455